FDA shakes up drug marketing units to achieve multiple goals

03/11/2013 | PharmExec.com

The FDA's Office of Prescription Drug Promotion is restructuring its professional and consumer marketing review divisions to provide tight supervision of direct-to-consumer advertising. The changes, which include organizing oversight by therapeutic class instead of target audience, will help achieve the goals of removing redundancy, enhancing work distribution and increasing efficiency, according to Center for Drug Evaluation and Research Director Dr. Janet Woodcock.

View Full Article in:

PharmExec.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC